Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.23.3
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Revenue
Operating expenses        
Research and development 2,158,167 1,723,493 5,365,641 4,017,564
General and administrative 344,758 659,568 1,126,192 1,128,007
Total operating expenses 2,502,925 2,383,061 6,491,833 5,145,571
Loss from operations (2,502,925) (2,383,061) (6,491,833) (5,145,571)
Interest Income 111,136 64,037 346,769 110,846
Net loss $ (2,391,789) $ (2,319,024) $ (6,145,064) $ (5,034,725)
Per share information:        
Net loss per common share, basic $ (0.19) $ (0.18) $ (0.48) $ (0.39)
Net loss per common share, diluted $ (0.19) $ (0.18) $ (0.48) $ (0.39)
Weighted average common shares outstanding, basic 12,848,165 12,823,447 12,848,165 13,067,620
Weighted average common shares outstanding, diluted 12,848,165 12,823,447 12,848,165 13,067,620